2 -STUDY PARTICIPANTS. It is critical that all the data and statistical analyses shown in the manuscript are conducted in the same subset of participants with complete data. The default behavior in many statistical packages is inadvertently removing participants with incomplete data from the models. Consequently, different adjustment models showing different associations may be purely due to inadvertently selecting model-specific subsets of participants. In order to show that all the analysis where conducted in the same subset of participants, a more detailed description of the final study population is needed. For instance, the "Subjects" section is lacking a sentence stating how many participants had complete follow-up data and both blood and urine cadmium measured at baseline and how many participants were excluded due to missing information on relevant peripheral arterial disease risk factors.
3-STATISTICAL METHODS
• In a prospective data analysis setting it is customary to exclude prevalent cases at baseline. In this study there is no ankle brachial index information collected at baseline, and the authors try to overcome this limitation by adjusting the models for the presence of plaques in the right femoral artery at baseline. In my opinion it may not be appropriate to adjust for the presence of plaques at the baseline, which can be not only a proxy for the outcome at baseline but also a proxy for the outcome at the end of follow-up. Adjusting for a proxy of the outcome is generally not recommended; consequently I suggest that the models are not adjusted for presence of plaque at baseline. Instead, a sensitivity analysis should be performed running the models in the subset of participants without plaques at baseline to check for consistency of findings. I understand that after excluding participants with femoral plaques at baseline the number of cases can be substantially diminished and it may not be possible to model cadmium exposure as tertiles. If this is the case the authors could conduct the sensitivity analysis modeling cadmium as a continuous log-transformed variable.
• The authors take into account the effect of the following potential confounders: pack-years, systolic blood pressure, HbA1c, ICAM-1, apolipoprotein B/A-I ratio and statin treatment at baseline. Note that if ICAM -1 would be a true mediator of the association of cadmium exposure and peripheral arterial disease, then including ICAM-1 in the models could result in overadjustment of this association. Therefore, the odds ratios reported in the abstract and results section should be the ones not adjusted for ICAM-1. Also, the models are not taking into account the confounding effect of uncontrolled dyslipemia, anti-hypertensive treatment and current smoking status. If the information is available, I suggest the authors also include these variables in the models.
• A stratified sampling procedure was used to recruit similarly-sized groups of women with normal, impaired and diabetic glucose tolerance. In order to account for a potential bias introduced by the frequency matching the models should be adjusted for normal, impaired and diabetic glucose tolerance status at baseline.
• Cell culture and cadmium incubation: I am not familiar with the laboratory methods described in the text. Therefore I cannot evaluate if the lack of findings in the mechanistic part of the study is due to any technical limitations. Someone with more expertise on those methods should review the manuscript. • A table 3 showing the odds ratios (95% confidence interval) for peripheral arterial disease by blood and urine cadmium tertiles in separate fully adjusted models with and without adjustment for ICAM -1 levels is lacking. I strongly recommend adding such a table. The attenuation of the cadmium-related odds ratios after introducing in the models ICAM-1 would support that ICAM-1 is a mediator of the association of cadmium exposure and peripheral arterial disease at the population level. A column with the number of cases/non cases by tertile category is also needed. This information should be made available to the readership because a low number of cases in the reference category can result in unstable odds ratio estimates for the tertiles 2 and 3 compared to the reference. Additionally, the cut-offs for the definition of blood and urine cadmium tertiles (percentiles 33 and 66) should be reported in the table. In addition to results from models with cadmium variables introduced as tertile categories, I suggest that authors also include results from logistic models with cadmium introduced as a continuous variable. Note that blood and urine cadmium are right skewed and they have to be logtransformed. For instance introducing the continuous cadmium variables as log2-transformed independent variables in logistic models, and exponentiating the corresponding coefficients, will estimate the odds ratio for peripheral arterial disease for the doubling of the cadmium dose. Using continuous variables as dependent variables is a more powerful approach, under the assumption of linearity.
RESULTS & CONCLUSIONS -RESULTS
• With respect to the association of log ICAM-1 and log blood and urinary cadmium reported in the Results section, I assume that the authors used linear regression with log ICAM-1 introduced as the dependent variable and log blood and urinary cadmium introduced as independent variable in separate models. I suggest that the authors report not only the p-value for the corresponding coefficients, but also, the geometric mean ratios (95%CI) of ICAM-1 per unit increase in log blood or urine cadmium levels, which can be obtained after exponentiating the corresponding coefficients and coefficients±1.96 standard errors. Note that it may be important to adjust for current smoking status and not only pack-years, as it is likely that the relevant exposure window associated to ICAM-1 is current smoking exposure (rather than accumulated smoking exposure).
-DISCUSSION • In the 2003-2008 US National Health and Nutrition Examination Surveys the geometric mean of urine cadmium in never smoker women >=65 year-old is ~0.40 μg/g creatinine. Compared to published data from other study populations, the US general population is among the populations showing the lowest levels of exposure. If, as reported in the first sentence of the Discussion section, the percentile 66 of the urine cadmium distributions is 0.48 μg/g in the study population, including smokers and non-smokers, it does not seem to me that the studied women are representative of highly exposed populations, as the authors mention in the discussion section.
• This study population only includes 64 year-old women. In the "Article summary" the authors appropriately point out that further studies in larger cohorts are needed. However, the lack of generalizability of the study findings to the general population and the need to conduct prospective studies in populations including men in addition to women with a broader age range should be also acknowledged in the limitations section.
GENERAL COMMENTS
This prospective study evaluates the association of cadmium exposure and peripheral arterial disease, and the potential mediating role of inter-cellular adhesion molecule-1 (ICAM-1), in a sample of the authors found strong prospective associations between cadmium exposure and peripheral arterial disease, supporting that cadmium is a cardiovascular risk factor. By showing that cadmium impacts the cardiovascular system in human populations, this study could substantially impact risk benefit analyses for cadmium environmental and biomonitoring safety standards. Consequently, this manuscript can be of great interest. However, before considering the manuscript acceptable for publication, the authors should address the following issues:
1. Objectives.
In the last paragraph of the introduction section the authors describe in detail that their interests are in testing whether changes in ICAM-1 levels are a mediating factor on the association between cadmium exposure and peripheral arterial disease. However, the study objectives do not seem to be well formulated. Is the primary objective to test the prospective association of cadmium exposure and peripheral arterial disease and the secondary objective to test the mediating role of ICAM-1? Please clarify the abstract and the end of the introduction section.
2. Study subjects. It is critical that all the data and statistical analyses shown in the manuscript are conducted in the same subset of participants with complete data. The default behavior in many statistical packages is inadvertently removing participants with incomplete data from the models. Consequently, different adjustment models showing different associations may be purely due to inadvertently selecting model-specific subsets of participants. In order to show that all the analysis where conducted in the same subset of participants, a more detailed description of the final study population is needed. For instance, the "Subjects" section is lacking a sentence stating how many participants had complete follow-up data and both blood and urine cadmium measured at baseline and how many participants were excluded due to missing information on relevant peripheral arterial disease risk factors.
3. Statistical analysis and results.
• In table 1, please add a column with the descriptive characteristics of the study participants in the overall sample.
• A table 3 showing the odds ratios (95% confidence interval) for peripheral arterial disease by blood and urine cadmium tertiles in separate fully adjusted models with and without adjustment for ICAM -1 levels is lacking. I strongly recommend adding such a table. The attenuation of the cadmium-related odds ratios after introducing in the models ICAM-1 would support that ICAM-1 is a mediator of the association of cadmium exposure and peripheral arterial disease at the population level. A column with the number of cases/non cases by tertile category is also needed. This information should be made available to the readership because a low number of cases in the reference category can result in unstable odds ratio estimates for the tertiles 2 and 3 compared to the reference. Additionally, the cut-offs for the definition of blood and urine cadmium tertiles (percentiles 33 and 66) should be reported in the table. In addition to results from models with cadmium variables introduced as tertile categories, I suggest that authors also include results from logistic models with cadmium introduced as a continuous variable. Note that blood and urine cadmium are right skewed and they have to be logtransformed. For instance introducing the continuous cadmium variables as log2-transformed independent variables in logistic models, and exponentiating the corresponding coefficients, will estimate the odds ratio for peripheral arterial disease for the doubling of the cadmium dose. Using continuous variables as dependent variables is a more powerful approach, under the assumption of linearity.
Discussion • In the 2003-2008 US National Health and Nutrition Examination
Surveys the geometric mean of urine cadmium in never smoker women >=65 year-old is ~0.40 μg/g creatinine. Compared to published data from other study populations, the US general population is among the populations showing the lowest levels of exposure. If, as reported in the first sentence of the Discussion section, the percentile 66 of the urine cadmium distributions is 0.48 μg/g in the study population, including smokers and non-smokers, it does not seem to me that the studied women are representative of highly exposed populations, as the authors mention in the discussion section.
• Please, note that in observational studies the losses to follow-up can typically induce selection bias, not confounding.
5. Cell culture and cadmium incubation.
• I am not familiar with the laboratory methods described in the text. Therefore I cannot evaluate if the lack of findings in the mechanistic part of the study is due to any technical limitations. Someone with more expertise on those methods should review the manuscript.
Minor comments.
1. The sample size calculation at the beginning of the statistical methods section is not needed. 2. How many participants had blood or urine cadmium levels below the detection limit? Did the authors use any imputation strategy for values below the detection limit? Please, include this information in the methods section.
3. The last sentence in page 8 lines 57 to 59 ("Pearson's correlation coefficient….") does not read well. 4. The second sentence in page 10 ("Tertiles 1 and 3…") does not read well. The important percentiles to be reported are the percentile 33 and 66 (i.e. the tertiles' cut-offs). Reporting the tertiles' percentiles 5, 50 and 95 is confusing and leads to nowhere. 5. Please, add the geometric means of blood and urine cadmium in the overall study population to the results section. p8: why were these low cadmium concentrations used ? Cd levels in the endothelium is known from animal experiments to be considerably higher than blood levels. The uptake of Cd in vitro most probably is considerably lower than in vivo because cells lose much of their capacity to take up cadmium when cultivated. If cadmium is precipitated by PBS, very minimal uptake by cells can be expected. p10-11: why was CdMT used at such low concentrations? Cd-MT can be expected to be taken up less thatn Cd-albumin that should preferrally have been used. p11 Discussion: The observed effect most probably is a combination effect with smoking, because no effect was seen among nonsmokers. This should be spointed out in the discussion. p12: The use of the experimental study to rule out the ICAM1 hypothesis may not necessarily be adequate if PBS was used in the culture medium.
REVIEWER

VERSION 1 -AUTHOR RESPONSE
Reviewer: Maria Tellez-Plaza
This prospective study evaluates the association of cadmium exposure and peripheral arterial disease, and the potential mediating role of inter-cellular adhesion molecule-1 (ICAM-1), in a sample of 64 year-old women from Gothenburg, Sweden. In this manuscript, the authors found strong prospective associations between cadmium exposure and peripheral arterial disease, supporting that cadmium is a cardiovascular risk factor. By showing that cadmium impacts the cardiovascular system in human populations, this study could substantially impact risk benefit analyses for cadmium environmental and biomonitoring safety standards. Consequently, this manuscript can be of great interest. However, before considering the manuscript acceptable for publication, the authors should address the following issues:
1. Objectives. In the last paragraph of the introduction section the authors describe in detail that their interests are in testing whether changes in ICAM-1 levels are a mediating factor on the association between cadmium exposure and peripheral arterial disease. However, the study objectives do not seem to be well formulated. Is the primary objective to test the prospective association of cadmium exposure and peripheral arterial disease and the secondary objective to test the mediating role of ICAM-1? Please clarify the abstract and the end of the introduction section.
Response: OK, the text has been amended in accordance with the suggestion.
Response: We have modified the manuscript in line with this suggestion and included only subjects with complete data on potential confounders and cadmium levels in blood/ urine (see end of Subjects paragraph). However, we have also included the 36 participants with complete data on potential confounders and cadmium assessed in blood or urine in order not to reduce the power of the study.
Response: OK, see new Table 1. • A table 3 showing the odds ratios (95% confidence interval) for peripheral arterial disease by blood and urine cadmium tertiles in separate fully adjusted models with and without adjustment for ICAM -1 levels is lacking. I strongly recommend adding such a table. The attenuation of the cadmium-related odds ratios after introducing in the models ICAM-1 would support that ICAM-1 is a mediator of the association of cadmium exposure and peripheral arterial disease at the population level. A column with the number of cases/non cases by tertile category is also needed. This information should be made available to the readership because a low number of cases in the reference category can result in unstable odds ratio estimates for the tertiles 2 and 3 compared to the reference. Additionally, the cut-offs for the definition of blood and urine cadmium tertiles (percentiles 33 and 66) should be reported in the table. In addition to results from models with cadmium variables introduced as tertile categories, I suggest that authors also include results from logistic models with cadmium introduced as a continuous variable. Note that blood and urine cadmium are right skewed and they have to be log-transformed. For instance introducing the continuous cadmium variables as log2-transformed independent variables in logistic models, and exponentiating the corresponding coefficients, will estimate the odds ratio for peripheral arterial disease for the doubling of the cadmium dose. Using continuous variables as dependent variables is a more powerful approach, under the assumption of linearity.
Response: We agree. Two new tables (#2 and 3) have been included in accordance with the suggestions to present results from analyses based upon blood and urinary cadmium, respectively. In addition we have included the sensitivity analyses when only plaque-free women at baseline were included (see below). The results give support to the hypothesis that cadmium is associated with the development of peripheral atherosclerosis. The data in Figure 1 , Tables 2 and 3 indicate that there is not a continuous association between cadmium levels at baseline and low ankle-brachial index at follow-up. This fact should explain the finding that neither log2 of blood nor urine cadmium is associated with low ankle-brachial index when the same calculations as in Table 2 and 3 are repeated (data not shown). This information is not presented in the revised manuscript, as it will be available in the present document.
Response: Good point -we have included these sensitivity analyses in the new Tables 2 and 3 (see  above) .
Response: We are grateful for this comment and have now excluded ICAM-1 from the adjusted model and made one final analysis with the addition of ICAM-1, as suggested above. We have also added current smoking and glucose tolerance status at baseline (see below) as potential confounders to the statistical model. We prefer not to include antihypertensive treatment and uncontrolled hyperlipidemia for three reasons: 1) the study has a limited sample size and the model now includes 8 independent variables. 2) antihypertensive treatment is now reported in Table 1 , but is not used in the model since a stepwise analysis showed that it did not contribute to the prediction; 3) uncontrolled dyslipidemia is covered by the variable apolipoprotein B/A-I, that captures the levels of both pro-and antiatherogenic lipoproteins (ref below).
Response: OK, see above.
Response: As assumed, current smoking was, in comparison with pack years, more associated with ICAM-1 levels. The following text has been added to the Result section: In a multiple regression analysis the associations between log ICAM-1 and log creatinine-corrected urinary cadmium levels remained after adjustment for current smoking and pack years, whereas this was not the case for log blood cadmium. The corresponding geometric mean ratios (95% CI) of ICAM-1 per unit increase in log urine or log blood cadmium levels were 1.13 (1.03-1.26) and 1.09 (0.96-1.24), respectively. Log ICAM-1 levels were mainly associated with current smoking in multivariate analysis (p<0.008).
Discussion
• In the 2003-2008 US National Health and Nutrition Examination Surveys the geometric mean of urine cadmium in never smoker women >=65 year-old is ~0.40 μg/g creatinine. Compared to published data from other study populations, the US general population is among the populations showing the lowest levels of exposure. If, as reported in the first sentence of the Discussion section, the percentile 66 of the urine cadmium distributions is 0.48 μg/g in the study population, including smokers and non-smokers, it does not seem to me that the studied women are representative of highly exposed populations, as the authors mention in the discussion section.
Response: We agree, and have deleted this sentence (it was based on the fact that within the Swedish general population, this group of older women have in relative terms high cadmium exposure also showed by the finding that no participant had cadmium levels below the detection limit).
Response: Of course, thank you. This has been corrected.
Response: The limitations section has been amended with the suggested text.
